PSTV’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -78.34%.However, over the last six months, we can see a stronger performance of -67.33%. Over the last 30 days, the price of PSTV has fallen by 92.00%. And in the last five days, it has surged by 15.61%.

Plus Therapeutics Inc (PSTV) currently has a stock price of $0.39. The stock saw a sharp increase in the last trading session, hitting a high of $20.5 after opening at $0.39. The lowest recorded price for the day was $3.0 before it closed at $0.37.

Plus Therapeutics Inc’s stock market performance has been somewhat irregular.

52-week price history of PSTV Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Plus Therapeutics Inc’s current trading price is -83.17% away from its 52-week high, while its distance from the 52-week low is 137.94%. The stock’s price range over this timeframe has been between $0.16 and $2.31. The shares of the Healthcare sector company recorded a trading volume of approximately 8.06 million for the day, which was comparatively lower than the average daily volume of 26.69 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Plus Therapeutics Inc (PSTV) has experienced a quarterly decline of -40.97% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 23.52M and boasts a workforce of 21 employees.

Expert Opinions: Analysts’ Ratings for Plus Therapeutics Inc

As of right now, 1 analyst is rating Plus Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6088, with a change in price of -0.6881. Similarly, Plus Therapeutics Inc recorded 26,692,521 in trading volume during the last 100 days, posting a change of -63.71%.

PSTV Stock Stochastic Average

The raw stochastic average for Plus Therapeutics Inc over the last 50 days is presently at 39.23%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 83.61%. Further, the company’s Stochastic %K and %D values for the last 20 days were 80.11% and 72.52%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.